Role of OCIAD1 in RIG-I-mediated STAT1 signaling pathway
OCIAD1 在 RIG-I 介导的 STAT1 信号通路中的作用
基本信息
- 批准号:10554293
- 负责人:
- 金额:$ 19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-24 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AntigensAntiviral AgentsAutoimmune DiseasesBindingBioinformaticsCellsDataEconomic BurdenEpithelial CellsGene ExpressionGenesGoalsHealthHost DefenseHumanITAMImmunityImpairmentInfectionInfluenzaInfluenza A virusInnate Immune ResponseIntegration Host FactorsInterferon Type IInterferonsKnockout MiceKnowledgeLinkLiteratureMalignant neoplasm of ovaryMediatingMitochondriaMolecularNatural ImmunityNucleic AcidsPathway interactionsPattern recognition receptorPhosphorylationProtein Tyrosine KinaseProteinsReportingRoleSTAT1 geneSYK geneSignal PathwaySignal TransductionSignaling MoleculeSignaling ProteinTANK-binding kinase 1TestingTracheal EpitheliumTretinoinViralViral ProteinsVirulenceVirusVirus DiseasesVirus Replicationcytokinedesignimmunoreactivityin vivoinfluenzavirusinsightnoveloverexpressionrecruitresponseviral RNA
项目摘要
Project summary
Host pattern recognition receptors, such as retinoic acid-induced gene I (RIG-I), sense viral RNA and elicit
interferon-mediated innate immunity to restrict viral infection. It is well-established that RIG-I induces type I
interferon (IFN) expression via the mitochondrial antiviral signaling protein (MAVS) and TANK-binding kinase 1
(TBK1). Type I IFN acts a danger signal and further activates the JAK-STAT signaling pathway to induce
interferon-stimulated genes (ISGs), thereby limiting viral infection. A recent study reported another RIG-I
signaling branch, in which MAVS directly induces STAT1 phosphorylation and ISG expression through the
tyrosine kinase SYK. The RIG-I-STAT1 signaling has been shown to be critical for host defense at the early
stage of viral infection. However, the critical intermediate signal molecule(s) linking MAVS and SYK is missing
in this signal cascade because MAVS does not have the immunoreceptor tyrosine-based activation motif
(ITAM) responsible for SYK binding and activation. Thus, there is a knowledge gap in the RIG-I-STAT1
signaling pathway. The objective in this application is to determine the role of the ovarian cancer
immunoreactive antigen domain containing 1 (OCIAD1) in the RIG-I-STAT1 signaling pathway and host
defense to viral infection. Although the RIG-I-STAT1 signaling pathway is established recently, there is a
missing link between MAVS and SYK. Bioinformatic analysis showed that OCIAD1 had an ITAM-like motif that
can recruit and activate SYK. Our preliminary data and previous studies showed that OCIAD1 interacted with
MAVS. Furthermore, deficiency of OCIAD1 impaired RIG-I-mediated STAT1 phosphorylation. In addition, we
and others reported that the NS2 protein of influenza A virus interacted with OCIAD1. Overexpression of NS2
blocked STAT1 phosphorylation. Thus, based on the existing literature and our preliminary data, we
hypothesize that OCIAD1 recruits SYK to the MAVS signalosome and activates STAT1 phosphorylation in the
RIG-I-STAT1 signaling pathway. Furthermore, influenza NS2 suppresses the RIG-I-STAT1 signaling pathway
by antagonizing OCIAD1. Aim 1 will determine the role of OCIAD1 in IAV infection in vivo and in human
primary cells. Aim 2 will dissect the molecular mechanisms of how OCIAD1 regulates the RIG-I-STAT1
signaling and how NS2 antagonizes this pathway.
Our study will bridge the gaps in the RIG-I-STAT1 signaling cascades and determine a potential role of NS2 in
subversion of host innate immune response, which will provide insights on a new viral strategy for evading host
defense surveillance. The findings in our study will not only help develop effective antiviral therapeutics but will
also deepen our understanding of host innate immune responses to viruses.
项目概要
宿主模式识别受体,例如视黄酸诱导基因 I (RIG-I),感知病毒 RNA 并引发
干扰素介导的先天免疫来限制病毒感染。众所周知,RIG-I 诱导 I 型
通过线粒体抗病毒信号蛋白 (MAVS) 和 TANK 结合激酶 1 表达干扰素 (IFN)
(TBK1)。 I 型 IFN 发出危险信号,进一步激活 JAK-STAT 信号通路,诱导
干扰素刺激基因(ISG),从而限制病毒感染。最近的一项研究报告了另一种 RIG-I
信号分支,其中 MAVS 通过直接诱导 STAT1 磷酸化和 ISG 表达
酪氨酸激酶 SYK。 RIG-I-STAT1 信号传导已被证明对于早期宿主防御至关重要。
病毒感染阶段。然而,连接 MAVS 和 SYK 的关键中间信号分子缺失
在此信号级联中,因为 MAVS 不具有基于免疫受体酪氨酸的激活基序
(ITAM) 负责 SYK 绑定和激活。因此,RIG-I-STAT1 中存在知识差距
信号通路。本申请的目的是确定卵巢癌的作用
RIG-I-STAT1 信号通路和宿主中含有免疫反应性抗原结构域 1 (OCIAD1)
防御病毒感染。尽管 RIG-I-STAT1 信号通路最近才建立,但仍有一个
MAVS 和 SYK 之间缺少链接。生物信息分析表明 OCIAD1 具有类似 ITAM 的基序
可以招募并激活SYK。我们的初步数据和之前的研究表明 OCIAD1 与
MAVS。此外,OCIAD1 的缺陷会损害 RIG-I 介导的 STAT1 磷酸化。此外,我们
等人报道甲型流感病毒的 NS2 蛋白与 OCIAD1 相互作用。 NS2 过度表达
阻断 STAT1 磷酸化。因此,根据现有文献和我们的初步数据,我们
假设 OCIAD1 将 SYK 招募到 MAVS 信号体并激活 STAT1 磷酸化
RIG-I-STAT1 信号通路。此外,流感 NS2 抑制 RIG-I-STAT1 信号通路
通过对抗OCIAD1。目标 1 将确定 OCIAD1 在体内和人类 IAV 感染中的作用
原代细胞。目标 2 将剖析 OCIAD1 如何调节 RIG-I-STAT1 的分子机制
信号传导以及 NS2 如何拮抗该通路。
我们的研究将弥合 RIG-I-STAT1 信号级联中的差距,并确定 NS2 在
颠覆宿主先天免疫反应,这将为逃避宿主的新病毒策略提供见解
国防监视。我们的研究结果不仅有助于开发有效的抗病毒疗法,而且将
也加深了我们对宿主对病毒的先天免疫反应的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shitao Li其他文献
Shitao Li的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shitao Li', 18)}}的其他基金
Role of OCIAD1 in RIG-I-mediated STAT1 signaling pathway
OCIAD1 在 RIG-I 介导的 STAT1 信号通路中的作用
- 批准号:
10410142 - 财政年份:2022
- 资助金额:
$ 19万 - 项目类别:
Phosphorylation mimetic motif of cryptochrome proteins blocks IRF3 activation
隐花色素蛋白的磷酸化模拟基序可阻断 IRF3 激活
- 批准号:
10583785 - 财政年份:2022
- 资助金额:
$ 19万 - 项目类别:
K63-linked ubiquitination regulates cGAS activation upon DNA damage
K63 连接的泛素化在 DNA 损伤时调节 cGAS 激活
- 批准号:
10348290 - 财政年份:2021
- 资助金额:
$ 19万 - 项目类别:
K63-linked ubiquitination regulates cGAS activation upon DNA damage
K63 连接的泛素化在 DNA 损伤时调节 cGAS 激活
- 批准号:
10495239 - 财政年份:2021
- 资助金额:
$ 19万 - 项目类别:
Role of FIP200 in RIG-I-mediated innate immunity
FIP200 在 RIG-I 介导的先天免疫中的作用
- 批准号:
10059138 - 财政年份:2018
- 资助金额:
$ 19万 - 项目类别:
Role of FIP200 in RIG-I-mediated innate immunity
FIP200 在 RIG-I 介导的先天免疫中的作用
- 批准号:
10295767 - 财政年份:2018
- 资助金额:
$ 19万 - 项目类别:
Regulation of cGAS-Mediated Cytosolic DNA Sensing Pathway
cGAS 介导的胞质 DNA 传感途径的调节
- 批准号:
10054489 - 财政年份:2018
- 资助金额:
$ 19万 - 项目类别:
Role of FIP200 in RIG-I-mediated innate immunity
FIP200 在 RIG-I 介导的先天免疫中的作用
- 批准号:
10507761 - 财政年份:2018
- 资助金额:
$ 19万 - 项目类别:
Taxilin Alpha Regulates DNA-Mediated and Interferon-Dependent Innate Immunity
Taxilin Alpha 调节 DNA 介导和干扰素依赖性先天免疫
- 批准号:
9303580 - 财政年份:2017
- 资助金额:
$ 19万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 19万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 19万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 19万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 19万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 19万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 19万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 19万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 19万 - 项目类别:














{{item.name}}会员




